These findings indicate that AMPK pathway is an important mediator for kidney cell function and suggest that BBR therapy that modulates AMPK signaling may be beneficial in treating kidney dysfunction in diabetic nephropathy. The gene discussed is PRKAA1; the disease is diabetic kidney disease.